Delivery Order SPE2DB20D3101-SPE2DB25FRWV1
- Not listed
- The Defense Logistics Agency awarded a $68,990 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, a typhoid vaccine product. This firm fixed-price, competitively awarded contract was executed on September 22, 2025, with an ultimate completion date of September 23, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $1,379.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-competitive, non-set-aside contract represents a small-value order for typhoid vaccine supplies to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $13,798 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract for a typhoid vaccine product. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a $6,209.10 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, a typhoid vaccine product. This firm fixed-price, non-set-aside delivery order was awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $18,736.79 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This firm fixed price, non-competitive delivery order was issued on June 23, 2025, with an ultimate completion date of June 24, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen...
- The Defense Logistics Agency awarded a $16,581.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This non-competitive delivery order, which must be completed by June 20, 2025, represents a small-value procurement from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $27,708.84 to AmerisourceBergen Drug Corp for the supply of TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This firm fixed price delivery order, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a non-competitive, non-set-aside procurement executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $24,644.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 13, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. Performance will be executed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $45,117.27 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product, with an ultimate completion date of June 26, 2025. The contract was awarded on a firm fixed-price basis with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $39,759.60 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes, a typhoid conjugate vaccine product. The contract is structured as a firm fixed price delivery order with a completion date of August 26, 2025, and represents a competitively awarded, non-set-aside procurement. The award will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRWV1Delivery Order
The Defense Logistics Agency awarded a $68,990 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, a typhoid vaccine product. The delivery order, issued on September 27, 2025, with an ultimate completion date of September 29, 2025, was competitively awarded without any set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill complex medical supply requirements across multiple therapeutic domains, including vaccines, specialty medications, and medical devices. This vaccine delivery order represents part of the company's ongoing support to DLA's medical supply chain operations that serve U.S. military personnel and supported beneficiary populations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $69.0k | 9/27/25 |